Cargando…
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
PURPOSE: In 2020, breast cancer still represents the most common type of cancer in women worldwide. Depending on the specific molecular subtype, clinical breast cancer management comprises surgery, radiotherapy, chemotherapy and targeted therapy. Furthermore, there are some therapeutic approaches fr...
Autores principales: | Klauser, Anna-Lena, Hirschfeld, Marc, Ritter, Andrea, Rücker, Gerta, Jäger, Markus, Gundarova, Julia, Weiss, Daniela, Juhasz-Böss, Ingolf, Berner, Kai, Erbes, Thalia, Asberger, Jasmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668161/ https://www.ncbi.nlm.nih.gov/pubmed/34916844 http://dx.doi.org/10.2147/BCTT.S322619 |
Ejemplares similares
-
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study
por: Berner, Kai, et al.
Publicado: (2021) -
Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins
por: Asberger, Jasmin, et al.
Publicado: (2020) -
Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
por: Ritter, Andrea, et al.
Publicado: (2019) -
In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer
por: Asberger, Jasmin, et al.
Publicado: (2023) -
Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature
por: Ge, Isabell, et al.
Publicado: (2022)